The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E

Table 2 RT-PCR confirmed HEV Patients’ demographic data, ALT, RT-PCR and serology results

Sample no	ALT	Nationality	Wantai HEV-IgG	Wantai HEV-IgM	MP HEV-Total Ab	CT-value**	Wantai HEV-Ag
34	2766	Indian	+	+	+	+	+
43	1314	Indian	+	+	+	(++) 23	+
44	2346	Indian	+	+	+	(+) 32	+
45	3569	Indian	−	+	+	(++) 22	+
46	40	Indian	+	+	+	(++) 29	−
49	ND	Egyptian	+	−	+	(+++)10	−
50	919	Bangladeshi	+	+	+	(+) 31	−
52	ND	Pakistanis	+	+	+	(+)36	+
53	ND	Bangladeshi	+	+	+	(+) 30	+
54	1321	Bangladeshi	+	+	+	(+) 31	−
55	107	Qatari	−	−	−	(+++)19	−
63	146	Egyptian	−	−	+	(+) 39	−
66	42	Nepalese	−	−	−	(+) 31	−
67	379	Indian	−	−	−	(+) 36	−
68	15	Qatari	−	−	−	(+) 39	−
72	947	Indian	+	ND*	+	(+) 30	+
74	396	Indian	+	+	+	(+) 32	−
75	1122	Indian	+	+	+	(+) 34	+
85	ND	Indian	ND	ND	ND	(++) 28	ND
86	91	Pakistanis	ND	ND	ND	(+) 38	ND
87	99	Pakistanis	−	+	+	(++) 20	−
88	103	Sudanese	+	+	+	(+) 30	−
89	ND	Nepalese	+	+	+	(+) 30	−
90	95	Siri Lankan	−	+	−	(+) 32	−

ALT reference range: 0 U/L–41 U/L
*ND Not done because of no sufficient sample
**(+++) or highly positive: CT value < 20; (++) or moderately positive: CT value from 20 to 30; (+) weakly positive: CT value between 30 and 40; (−) or negative CT value less than 45 considered negative

ISSN: 1471-230X